TripSitter Clinic Ltd.
TSTTF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | -97.1% | 459.8% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $1 |
| Gross Profit | $0 | $0 | $0 | -$1 |
| % Margin | – | 100% | 28.4% | -635.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $1 | $2 |
| SG&A Expenses | $0 | $0 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Expenses | $0 | $0 | $2 | $2 |
| Operating Income | -$0 | -$0 | -$2 | -$2 |
| % Margin | – | -2,493.6% | -379.3% | -2,607.5% |
| Other Income/Exp. Net | $0 | $0 | -$0 | $0 |
| Pre-Tax Income | -$0 | -$0 | -$2 | -$10 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$2 | -$10 |
| % Margin | – | -2,181.5% | -382.7% | -11,717.4% |
| EPS | -0.001 | -0.005 | -0.031 | -0.43 |
| % Growth | 69.6% | 85.2% | 92.8% | – |
| EPS Diluted | -0.001 | -0.005 | -0.031 | -0.43 |
| Weighted Avg Shares Out | 7 | 67 | 61 | 61 |
| Weighted Avg Shares Out Dil | 7 | 67 | 61 | 61 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $16 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$2 | -$2 |
| % Margin | – | -2,493.6% | -379.3% | -2,607.5% |